New ZX10 boasts powerful AI-ready performance,intuitive Android functionality,and fully rugged reliability,making it ideally suited to challenging field-based tasks
01-15
NEW HAVEN,Conn.,Jan. 13,2025-- XingImaging,a MITRO company,a leader in advanced research imaging and radiopharmaceutical services,is excited to announce the opening of its new state-of-the art resear
01-14
BELLEVUE,Wash.,Jan. 13,2025-- Anker Innovations,a global leader in mobile charging and consumer electronics,today unveiled its latest groundbreaking charging innovations at the Consumer Electronics Sh
01-14
MELBOURNE,Australiaand LIÈGE,Belgium,Jan. 13,2025-- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX,Telix,the Company) today announces that it has entered into an agreement with Curium Ph
01-14
The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro,extending ZEISS\' LVC market leadership with treatment for myopia,hyperopia,and mixed astigmatism.
01-14
HONG KONG,Jan. 13,2025-- Gianna Lullume,an innovative brand committed to improving infant sleep and promoting family well-being,is proud to announce the official launch of its crowdfunding campaign on
01-14
MELBOURNE,Australiaand INDIANAPOLIS,Jan. 13,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) today announces it has entered into an asset purchase agreement with antibody
01-13
LAS VEGAS,Jan. 11,2025-- AtCES 2025,MLVision has officially launched its groundbreaking MLVision M5,setting a new global standard for wearable technology. Weighing a mere 25.8 grams,the MLVision M5 is
01-13
This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform,similar to the preclinical stage KAT6 inhibitor (MEN2312) licens
01-13
HANGZHOU,China,Jan. 10,2025--HangzhouSciwind Biosciences Co.,a pre-commercial biopharmaceutical company focusing on developing innovative therapies to treat metabolic diseases,today announced a licens
01-11
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Diet Tips Daily
